During the past decade, Eurofins Optimed conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eurofins Optimed" #1 sponsor was "Tools4Patient" with 3 trials, followed by "Calliditas Therapeutics AB" with 2 trials sponsored, "Danisco" with 2 trials sponsored, "Genfit" with 2 trials sponsored and "Lesaffre International" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eurofins Optimed" #1 collaborator was "Eurofins Optimed" with 9 trials as a collaborator, "Biofortis Mérieux NutriSciences" with 2 trials as a collaborator, "BioFortis" with 1 trials as a collaborator, "CardiaBase" with 1 trials as a collaborator and "International Drug Development Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Eurofins Optimed" are "Healthy Volunteers" (5 trials), "Osteoarthritis" (3 trials), "Cardiovascular Diseases" (2 trials), "Healthy Subjects" (2 trials) and "Phase 1" (2 trials). Many other conditions were trialed in "Eurofins Optimed" in a lesser frequency.

Most popular intervention types in "Eurofins Optimed" are "Drug" (19 trials), "Dietary Supplement" (11 trials), "Other" (5 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "MD1003" (2 trials), "Theobromine" (2 trials), "Active product" (1 trials) and "Administration of Placebo capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eurofins Optimed" are 24 trials for "All" genders, 7 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Eurofins Optimed". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Eurofins Optimed, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eurofins Optimed, 16 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".